The Washington Post, August 5, 2013. The Post article on the overdiagnosis of cancer clearly reported the need to reduce patients’ fear and confusion about “cancers” that many experts now agree are not really cancer, because they don’t spread and aren’t harmful. The major obstacle has been uncertainty about how likely these conditions are to predict cancer or change into an invasive cancer in the future.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
The REAL Threat to Women’s Health
July 30, 2013. Given the higher death rate from cosmetic surgery and the much larger number of women undergoing cosmetic surgeries and procedures, why is it that the legislators in Texas, Virginia, Alabama, Mississippi, North Dakota, and so many other states are so concerned about the safety of abortion clinics?
Read More »FDA Kicks Off Women’s Health Program With Surgical Mesh Registry
FDA Week, June 27, 2013. FDA’s launch of a new registry for controversial surgical transvaginal mesh products as part of a new program focusing on women’s health could signal the agency is planning to prioritize sex-specific device concerns, a consumer advocate said. “If they start with new patients, it will take years before we get the information that we need,” said Diana Zuckerman, president of the National Research Center for Women & Families.
Read More »FDA Panels: Too Many Conflicts or Too Little Expertise?
Pharmalive.com, June 12, 2013. Should FDA Advisory Committee members be allowed to have financial conflicts of interest regarding the approval of medical products? Diana Zuckerman discusses how financial ties to pharmaceutical companies can influence the voting and discussion on drug and medical device approvals, and how misunderstandings of statistics and the value of clinical trials can lead to the approval of dangerous products.
Read More »Maryland Playground Closes Due to Possible Toxicity
NBC4 Washington, June 13, 2013. Diana Zuckerman with the Cancer Prevention and Treatment Fund said parents had good reason to be concerned about rubber mulch. “Rubber mulch contains phthalates, which are chemicals that affect hormones, and other chemicals that are known to be harmful to our health,” Zuckerman said.
Read More »


